Anti-SARS-CoV-2 Spike Nanobody (VHH), Recombinant, Purified

Anti-SARS-CoV-2 Spike Nanobody (VHH), Recombinant, Purified

Catalog #: EG-NB-SPK01
$425.00
View Cart
3D Structure — Nanobody–Epitope Complex
Loading 3D structure…
anti-SARS-CoV-2 Spike RBD nanobody complex
PDB 7KLW
nanobody (VHH)   antigen   epitope (22)
Drag to rotate · scroll to zoom

Interactive model of the VHH bound to its structural epitope on SARS-CoV-2 Spike RBD (from experimental complex PDB 7KLW). Nanobody in blue, epitope contact residues in red. For research visualization.

Product Description
Product NameAnti-SARS-CoV-2 Spike Nanobody (VHH), Recombinant, Purified
DescriptionA purified, engineered VHH nanobody against the SARS-CoV-2 Spike S1 subunit for neutralization and diagnostic research.
Target / SpecificitySARS-CoV-2 Spike glycoprotein (S1 / receptor-binding domain)
SequenceThis nanobody is an engineered variant based on PDB 7KLW, with higher affinity and stability than the original published sequence.
FormatPurified recombinant single-domain antibody (VHH / nanobody), carrier-free
Tag & ExpressionC-terminal 6×His tag; secreted from HEK293 cells and purified by one-step IMAC from the culture medium.
Molecular Weight~14 kDa (single VHH domain + His6; ~1/10 the size of a conventional IgG)
Purity>90% by SDS-PAGE
Quantity100 µg
FormulationPBS with 50% glycerol (carrier-free); 0.02% sodium azide
ApplicationsELISA, WB, IF, neutralization and diagnostic research
Structural EpitopeEpitope mapped from the experimental VHH–antigen complex (PDB 7KLW); 22 antigen contact residues within 5 Å. An interactive 3D complex model is shown on this page.
StorageStore at -20°C; avoid repeated freeze-thaw. Stable 1 year.
AdvantagesNanobodies are the smallest functional antibody fragments: exceptional thermal and chemical stability, single-domain, high-yield recombinant production, and access to cryptic epitopes and dense tissue that conventional antibodies cannot reach.
Product Documents
DatasheetEG-NB-SPK01 Product Datasheet
Download PDF
Related Products